Texas Attorney General
TX-AG v. Shire PLC, Baxter International Inc., Baxalta Inc., Viropharma Inc., Takeda Pharmaceuticals U.S.A., Inc., and Takeda Pharmaceuticals America
Settled
Shire PLC, Baxter International Inc., Baxalta Inc., Viropharma Inc., Takeda Pharmaceuticals U.S.A., Inc., and Takeda Pharmaceuticals America allegedly violated the TMFPA by providing, directly or indirectly, nursing and reimbursement services to Texas Medicaid providers for certain pharmaceutical drugs, as well as by paying clinical nurse educators to refer or recommend the drug Vyvanse to providers from January 2014 to December 2015, according to the TX-AG.
Summary generated from official Texas Attorney General press release
Source: Texas Attorney General Press Release ↗Parties
Defendants / Respondents
- Shire PLC
- Baxter International Inc.
- Baxalta Inc.
- Viropharma Inc.
- Takeda Pharmaceuticals U.S.A., Inc.
- Takeda Pharmaceuticals America
Dates
Resolved
August 7, 2023
Published
August 8, 2023
Case Details
Industry
Pharmaceutical
Penalty Type
Multiple